Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Latest filing published 06 Mar 2023 for Sesen Bio, Inc., €42k.
Filing timeline
BuySaleGlen C. MacDonald
Insider track record
Disclosed buys
0
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Glen C. MacDonald: trading record in brief
All filings by Glen C. MacDonald on record concern Sesen Bio, Inc., in the capacity of senior executive. In total, 7 filings cover trades dated from 18 February 2022 to 2 March 2023.
No open-market purchase appears, only 4 sales worth €108k. Besides market trades, the filings include 1 share grant and 2 option exercises. Since January 2023: no purchases and 4 sales on the market.
Most recently, on 6 March 2023, the filings show an option exercise worth €101k in Sesen Bio, Inc. Typically, a trade is published a median of 4 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Glen C. MacDonald
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
76,247 shares@ US$0.58774.6% of flowCommon StockSEC:0001485003-23-000109:0
25,927 shares@ US$0.587325.4% of flowCommon StockSEC:0001485003-23-000058:0
308,925 shares0Common StockSEC:0001485003-22-000018:0
3 of 3 declarations
